ADGRE1 and cancer: The use of fluorescence markers in conjunction with COPAS, such as AJM-1::GFP or egl-17p::EMR-1::RFP to mark the pseudovulvae, could enable high-throughput screening methods for new anti-cancer drugs in our model system.